Allergen-specific intralymphatic immunotherapy in human and animal studies
- Authors
- Kim, Seon Tae; Park, So Hyun; Lee, Sang Min; Lee, Sang Pyo
- Issue Date
- Jul-2017
- Publisher
- ASIA PACIFIC ASSOC ALLERGY, ASTHMA & CLINICAL IMMUNOLOGY
- Keywords
- Immunotherapy; Injections; intralymphatic; Treatment efficacy; Adverse effects
- Citation
- ASIA PACIFIC ALLERGY, v.7, no.3, pp.131 - 137
- Journal Title
- ASIA PACIFIC ALLERGY
- Volume
- 7
- Number
- 3
- Start Page
- 131
- End Page
- 137
- URI
- https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/5987
- DOI
- 10.5415/apallergy.2017.7.3.131
- ISSN
- 2233-8276
- Abstract
- Clinical trials of intralymphatic immunotherapy (ILIT) have been performed to overcome the limitations of long-term therapy and the local or systemic hypersensitivity reactions in conventional allergen-specific immunotherapy, including subcutaneous or sublingual immunotherapy. Additionally, several animal studies of ILIT have been conducted in the form of translational or veterinary research. We conducted a literature review to examine the treatment efficacy and adverse effects of ILIT.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 의과대학 > 의학과 > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/5987)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.